CAS: 17737-65-4; 2-(3-Chloro-2-Methylanilino)Pyridine-3-Carboxylic Acid

该化合物是一种非类固醇抗炎药物,主要用于其止痛和抗炎特性,其特点是能够抑制环氧酶(COX)酶,它在合成丙烯菊酯,炎炎和疼痛信号的化合物方面起着关键作用;氯苯辛一般以钠盐的形式施用,以治疗与各种疾病有关的疼痛和炎症为名,其治疗效果如疼痛和炎痛等;该物质在口服时一般是很好的吸食,其药性肿瘤在肝脏中含有新陈代谢,主要通过肾脏排出;氯苯丙胺在合成丙烯时可能具有共同的副作用,包括胃肠不适和潜在的肾脏效应,需要预先对患者提出警告;其化学结构包括一条肾脏环,有助于其药性活性.由于所有药物的使用,所以在安全性监督之下,氯丁胺是使用.

结构式图片

相似化合物

57978-41-3 57978-49-1 17782-05-7

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号2942-59-8 2-氯烟酸 | CAS号87-60-5 3-氯-2-甲基苯胺

合成工艺路线路线简述

  • 合成目标产物 Clonixin 主要起始原料 2-Chloronicotinic Acid And 3-Chloro-2-Methylaniline
  • (文献来源)合成步骤主要原料 2-Chloronicotinic Acid 和 3-Chloro-2-Methylaniline
2-氯烟酸,3-氯-2-甲基苯胺置于对甲苯磺酸一水合物,Potassium Hydroxide体系中,用 水 用作溶剂,以72.1 %的收率获得2-(3-氯邻甲苯氨基)烟酸
参考文献: Sting Modulators,Compositions,And Methods Of Use[fr] Modulateurs De Sting,Compositions Et Méthodes D'Utilisation
标题: Sting Modulators,Compositions,And Methods Of Use[fr] Modulateurs De Sting,Compositions Et Méthodes D'Utilisation
摘要:The Present Disclosure Is Directed To Compounds Of Formula (I),Or Pharmaceutically Acceptable Salts Thereof And Compounds Of Formula (II),Or Pharmaceutically Acceptable Salts Thereof,That Modulate Stimulator Of Interferon Genes (Sting),Compositions Comprising Such Compounds,And Methods Of Using Same For The Treatment Of Disorders Such As Cancer And Autoimmune Disease.

海关参考信息

专利信息


专利号:WO-2024262824-A1
优先权日:2023-06-20
标 题 :Novel process for synthesis of polysubstituted pyridine derivatives
发明人:PARK SEUNG BUM; YI SIHYEONG
权利人:SEOUL NAT UNIV R&DB FOUNDATION
摘要:The present invention relates to a novel method for synthesizing a polysubstituted pyridine derivative and, more specifically, to a method for synthesizing a 2,3,5-substituted pyridine derivative through a specific ring cleavage reaction. In the synthesis method of the present invention, an enamine structure is formed in situ by using beta keto ester/sulfone/phosphonic acid ester and ammonium acetate and subjected to an aldol condensation reaction with 3-formyl (aza) indole/benzofuran, a cyclization reaction, and a ring-cleavage reaction in that order to synthesize a characteristic pyridine structure having an alkyl/aryl substituent attached to the 2-position thereof, an ester/sulfone/phosphonic acid ester attached to the 3-position thereof, and ortho-aminoaryl/phenol including various substituents attached to the 5-position thereof. In particular, (aza)indole/benzofuran and beta keto ester/sulfone/phosphonic acid ester, which are reaction substrates, are substrates having very high accessibility, and enable the introduction of various substituents, thereby constructing a pyridine skeleton having high biocompatibility into which ortho-aminoaryl or phenol substituents having various substituents are introduced.

专利号:US-9051302-B2
优先权日:2008-01-15
标 题 :Synthesis of resorcylic acid lactones useful as therapeutic agents
发明人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN
权利人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN; UNIV STRASBOURG
摘要:Disclosed are macrocyclic compounds of formulae I, I′, II, II′, III, III′, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.

专利号:US-8017776-B2
优先权日:2003-07-15
标题 :Methods for synthesis of acyloxyalkyl compounds
发明人:BHAT LAXMINARAYAN; GALLOP MARK A
权利人:XENOPORT INC
摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

专利号:US-2024287041-A1
优先权日:2021-05-20
标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
权利人:KARYOPHARM THERAPEUTICS INC
摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

专利号:US-4255581-A
优先权日:1979-08-13
标题 :Process for the preparation of alkyl and aryl esters of 3'-substituted and 2', 3'-disubstituted 2-anilino-3-pyridinecarboxylic acids
发明人:LOS MARIO A
权利人:LAB BAGO S A
摘要:In this disclosure, the synthesis of alkyl and aryl esters of substituted 2-anilino-3-pyridinecarboxylic acids is described. This preparation is performed reacting a previously obtained alkyl or aryl ester of 2-chloro-3-pyridinecarboxylic acid, with 3,2 or 3-substituted aniline.

专利号:WO-0049038-A9
优先权日:1999-02-19
标题 :Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
发明人:SCHUBERT ULRICH; HENKLEIN PETER; WRAY VICTOR
权利人:SCHUBERT ULRICH; HENKLEIN PETER; WRAY VICTOR
摘要:The invention relates to synthetic (s) peptides of regulatory virus protein R (Vpr) of human immunodeficiency virus type 1(HIV-1), especially the total chemical synthesis of 96 aminoacid long Vpr protein (sVpr1-96), a 47 aminoacid long N terminal fragment (sVpr1-47) and a 49 aminoacid long C terminal fragment thereof (sVpr48-96) and to fragments sVpr1-20 and sVpr21-40, in addition to other fragments with approximately 15 aminoacids. Said products are used as HIV-1 regulatory proteins in biological assays and in the analysis of molecular structure and physico-chemical properties of Vpr and its domains or in the production of antibodies directed against Vpr-peptide sequences.
烟台亿鑫精细化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.ytyxchem.com
企业联系电话:13792556584👤
📞烟台亿鑫精细化工有限公司 ⚠️参考联系方式
联系人:李经理
电话:13792556584

传真:0535-6937807
邮箱:market@yxfinechem.com info@yxfinechem.com
通信地址: 烟台开发区松花江路11号
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:烟台开发区松花江路11号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Russmann S, Dilger K, Trenk D, Nagyivanyi P, Jähnchen E. Effect of lysine clonixinate on the pharmacokinetics and anticoagulant activity of phenprocoumon. Arzneimittelforschung. 2001 Nov;51(11):891-5.
8: Noronha VR, Gurgel GD, Alves LC, Noman-Ferreira LC, Mendonça LL, Aguiar EG, Abdo EN. Analgesic efficacy of lysine clonixinate, paracetamol and dipyrone in lower third molar extraction: a randomized controlled trial. Med Oral Patol Oral Cir Bucal. 2009 Aug 1;14(8):e411-5. Portuguese.

合成参考文献


摘要:Oyo Yakuri. Pharmacometrics., 7(655), 1973
参考文献:10.1136/vr.139.5.117
摘要:Scott PR, Gessert ME. Watery mouth disease in lambs: biochemical parameters before and after treatment. Vet Rec. 1996 Aug 03;139(5):117–8. doi: 10.1136/vr.139.5.117.
参考文献:10.2165/00002018-199615010-00002
摘要:Radbruch L, Grond S, Lehmann KA. A risk-benefit assessment of tramadol in the management of pain. Drug Saf. 1996 Jul;15(1):8–29. doi: 10.2165/00002018-199615010-00002.
参考文献:10.1007/bf00203776|10.1007/s002280050030
摘要:Pallapies D, Muhs A, Bertram L, Rohleder G, Nagyivnyi P, Peskar BA. Effects of single oral doses of lysine clonixinate and acetylsalicylic acid on platelet functions in man. European Journal of Clinical Pharmacology. 1996 Feb 01;49(5):351–4. doi: 10.1007/s002280050030.
摘要:Mathews KA, Paley DM, Foster RA, Valliant AE, Young SS. A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs. Can Vet J. 1996 Sep;37(9):557–67.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知